135 related articles for article (PubMed ID: 3337860)
1. Neurochemical changes in rat brain amines after short- and long-term inhibition of monoamine oxidase by a low dose of tranylcypromine.
Hampson DR; Baker GB; Coutts RT
Biol Psychiatry; 1988 Feb; 23(3):227-36. PubMed ID: 3337860
[TBL] [Abstract][Full Text] [Related]
2. Brain levels of 5-hydroxytryptamine, tryptamine and 2-phenylethylamine in the rat after administration of N-cyanoethyltranylcypromine.
Baker GB; Nazarali AJ; Coutts RT; Micetich RG; Hall TW
Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(4-6):657-60. PubMed ID: 6531437
[TBL] [Abstract][Full Text] [Related]
3. Neurochemical and neuropharmacological properties of 4-fluorotranylcypromine.
Coutts RT; Rao TS; Baker GB; Micetich RG; Hall TW
Cell Mol Neurobiol; 1987 Sep; 7(3):271-90. PubMed ID: 3440283
[TBL] [Abstract][Full Text] [Related]
4. N-propargylbenzylamine, a major metabolite of pargyline, is a potent inhibitor of monoamine oxidase type B in rats in vivo: a comparison with deprenyl.
Karoum F
Br J Pharmacol; 1987 Feb; 90(2):335-45. PubMed ID: 3103805
[TBL] [Abstract][Full Text] [Related]
5. Effects of monoamine oxidase inhibition by clorgyline, deprenil or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration.
Green AR; Youdim MB
Br J Pharmacol; 1975 Nov; 55(3):415-22. PubMed ID: 1203627
[TBL] [Abstract][Full Text] [Related]
6. 4-Methoxytranylcypromine, a monoamine oxidase inhibitor: effects on biogenic amines in rat brain following chronic administration.
Sherry-McKenna RL; Baker GB; Mousseau DD; Coutts RT; Dewhurst WG
Biol Psychiatry; 1992 May; 31(9):881-8. PubMed ID: 1353376
[TBL] [Abstract][Full Text] [Related]
7. Ring-substituted analogues of tranylcypromine as monoamine oxidase inhibitors.
Sherry RL; Baker GB; Coutts RT; Mousseau DD
J Neural Transm Suppl; 1990; 32():107-12. PubMed ID: 1982446
[TBL] [Abstract][Full Text] [Related]
8. Reversible, amine--selective effects of acute and chronic brofaromine treatment in the rat.
Dyck LE; Boulton AA
Life Sci; 1992; 51(1):59-66. PubMed ID: 1614274
[TBL] [Abstract][Full Text] [Related]
9. Gas-liquid chromatography and mass spectrometry of biogenic amines and amphetamines as their isothiocyanate derivatives.
Narasimhachari N; Vouros P
Anal Biochem; 1972 Jan; 45(1):154-63. PubMed ID: 5009281
[No Abstract] [Full Text] [Related]
10. Rat brain concentrations of 5-hydroxytryptamine following acute and chronic administration of MAO-inhibiting antidepressants.
Baker GB; LeGatt DF; Coutts RT; Dewhurst WG
Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(4-6):653-6. PubMed ID: 6531436
[TBL] [Abstract][Full Text] [Related]
11. Demonstration of biogenic amines and localization of monoamine oxidases in the sea anemone Metridium senile (Linné).
Lenicque PM; Toneby MI; Doumenc D
Comp Biochem Physiol C Comp Pharmacol; 1977; 56(1):31-4. PubMed ID: 11950
[No Abstract] [Full Text] [Related]
12. The role of noradrenaline, dopamine and 5-hydroxytryptamine in the hyperactivity response resulting from the administration of tranylcypramine to rats pretreated with lithium or rubidium.
Judd A; Parker J; Jenner FA
Psychopharmacologia; 1975 Apr; 42(1):73-7. PubMed ID: 1153625
[TBL] [Abstract][Full Text] [Related]
13. N,N-dipropargyl-2-phenylethylamine, a potential prodrug of 2-phenylethylamine: neurochemical and neuropharmacological studies in rat.
Rao TS; Baker GB; Coutts RT
Brain Res Bull; 1987 Jul; 19(1):47-55. PubMed ID: 3651840
[TBL] [Abstract][Full Text] [Related]
14. N2-acetylphenelzine: effects on rat brain GABA, alanine and biogenic amines.
McKenna KF; Baker GB; Coutts RT
Naunyn Schmiedebergs Arch Pharmacol; 1991 May; 343(5):478-82. PubMed ID: 1881457
[TBL] [Abstract][Full Text] [Related]
15. Monoamine oxidase in pancreatic islets, exocrine pancreas, and liver from rats. Characterization with clorgyline, deprenyl, pargyline, tranylcypromine, and amezinium.
Lenzen S; Nahrstedt H; Panten U
Naunyn Schmiedebergs Arch Pharmacol; 1983 Nov; 324(3):190-5. PubMed ID: 6419132
[TBL] [Abstract][Full Text] [Related]
16. Epinephrine accumulation in rat brain after chronic administration of pargyline and LY 51641--comparison with other brain amines.
Mefford IN; Roth KA; Jurik SM; Collman V; McIntire S; Tolbert L; Barchas JD
Brain Res; 1985 Jul; 339(2):342-5. PubMed ID: 2411347
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of D-phenylalanine and its effects on concentrations of brain monoamines and amino acids in rats--a basic study on possibility of clinical use of D-phenylalanine as an antidepressant.
Hashimoto H; Nakajima T; Nishimura T; Kudo Y; Takeda Y; Nakao M; Kanaya H; Horiguchi Y
Folia Psychiatr Neurol Jpn; 1983; 37(2):137-44. PubMed ID: 6671633
[TBL] [Abstract][Full Text] [Related]
18. Effect of styrene on levels of serotonin, noradrenaline, dopamine and activity of acetyl cholinesterase and monoamine oxidase in rat brain.
Husain R; Srivastava SP; Mushtaq M; Seth PK
Toxicol Lett; 1980 Nov; 7(1):47-50. PubMed ID: 7292514
[TBL] [Abstract][Full Text] [Related]
19. Ontogenetic development of the monoamine oxidase activity and of the metabolism of biogenic monoamines in rat brain.
Stancheva S; Grahovska T; Petkov VV
Acta Physiol Pharmacol Bulg; 1985; 11(1):3-9. PubMed ID: 4036650
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic and neurochemical studies on N-propargyl-2-phenylethylamine, a prodrug of 2-phenylethylamine.
Rao TS; Baker GB; Coutts RT
Naunyn Schmiedebergs Arch Pharmacol; 1987 Jul; 336(1):25-32. PubMed ID: 3627289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
